NEW YORK--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Biolase’s business and future prospects, resulting in its stock trading at inflated prices.
Select Embed Format:
Display in slide mode
Include related documents
Include other documents by this user
Full Screen link:
Pages to are hidden for
"Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Biolase, Inc"